Journal of Pharmacy Management - Oct 2019

AIM OF THE JoPM The aim of the JoPM is to play an influential and key part in shaping pharmacy practice and the role that medicines can play. The JoPM provides a vehicle to enable healthcare professionals to stimulate ideas in colleagues and/or disseminate good practice that others can adapt or develop to suit their local circumstances. READERSHIP The JoPM is made available on a controlled circulation basis to senior pharmacists in primary and secondary care and industry colleagues who work with them. EDITORIAL STAFF The JoPM is supported with the staff shown at the end of the journal. EDITORIAL BOARD A range of experience covering various organisations is available to help steer the development of the JoPM and ensure that it provides a useful resource for readers. Details of membership of the Editorial Board are shown at the end of the journal. PEER REVIEW/CLINICAL CONSULTANCY NETWORK The JoPM has a network of persons available to provide advice and undertake peer review of articles. Material that appears in the Best Practice and, as appropriate, the Clarion Call sections will have been subject to peer review. The emphasis in the JoPM is on disseminating best practice through good quality publications. The aim of the peer review process is to provide advice on the suitability of an article for publication as well constructive comment to assist authors, where appropriate, to develop their paper to a publishable standard. Peer review is conducted on a single blind basis and authors are not informed of the name(s) of Peer Reviewers. Peer Reviewers are required to declare any conflicts of interest they have regarding a particular manuscript and to exclude themselves from the peer review process if these could significantly complicate their review or inappropriately bias their opinion. Manuscripts are treated as confidential and it is a requirement that Peer Reviewers do not share or discuss it with colleagues. It is a requirement that Peer Reviewers should not use knowledge of the work they are reviewing before its publication to further their own interests. Peer Reviewers provide advice to the Editor-in-Chief. Where there is a significant variation of views at least one other Peer Reviewer may be contacted for advice before a final-decision is made regarding the outcome for the manuscript. The Editor-in-Chief is ultimately responsible for the selection of all content. COMMUNICATION CHANNELS A learned journal should open its pages to scholarly debate and we hope that readers will share their views and questions in the following ways. LINKEDIN Readers who use LinkedIn may like to know that there is a JoPM LinkedIn Group. It is a closed group but everyone who requests the JoPM will be permitted to join. Readers are encouraged to comment upon and discuss items about pharmacy practice. TWITTER Readers are encouraged to follow Pharmacy Management on @pharman to use our dedicated Twitter hashtag #(jopm) to draw attention to and debate topical issues having to do with pharmacy practice. CORRESPONDENCE Constructive comment to further understanding and debate about a topic is encouraged and welcomed. Any competing or conflicting interests should be declared at the time that the correspondence is submitted. Correspondence should be submitted within one month of the distribution date for the Journal. Correspondence may not be accepted in certain circumstances e.g. if it is discourteous, inaccurate, potentially libellous, irrelevant, uninteresting or lacks cogency. Correspondence may be edited for length, grammatical correctness, and journal style. Authors of articles discussed in correspondence will be given the opportunity to respond. The correspondence, together with a declaration of any interests and any subsequent comment from the author, may be published in the Journal and/or on the website. Please submit your correspondence to the Correspondence Editor ([email protected]). READERS’ FEEDBACK The comments of readers on each edition of the journal are welcomed. Please see the hyperlink provided elsewhere in the journal in the Readers' Feedback section to complete a short SurveyMonkey questionnaire. PUBLISHING YOUR WORK The JoPM aims to disseminate good practice about pharmacy practice.. The JoPM aims to follow the ‘Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals’ published by the International Committee of Medical Journal Editors (ICMJE) and known as ‘The Uniform Requirements’ and the Committee on Publication Ethics (COPE) ‘Code of Conduct’. Guidance for Authors is available under the 'Journals' tab at: www.pharman.co.uk . All material should be sent electronically to the Editor-in-Chief ([email protected]). HYPERLINKS References and other resource material as appropriate can be accessed directly via hyperlinks in the Journal. SUBSCRIPTION The JoPM is free of charge to healthcare professionals working for the NHS. REGISTRATION To receive the JoPM, please go to www.pharman.co.uk , c lick on the ‘PM Journals’ tab and follow the process for registration. ADVERTISEMENTS/ADVERTORIALS Please contact the Advertising Editor (see end of journal) for more information. ACCREDITATION The JoPM has been Faculty accredited by the Royal Pharmaceutical Society. By achieving Royal Pharmaceutical Society Faculty accreditation it has been demonstrated that our published material meets the recognised Royal Pharmaceutical Society standards for quality and content and that we are committed to pursuing excellence. DISCLAIMER Published by: Pharman Limited, 75c High Street, Great Dunmow, Essex CM6 1AE Tel: 01371 874478 Homepage: see under the 'Journals' tab at: www.pharman.co.uk . Email: [email protected] All rights reserved. No part of this publication may be reproduced, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of Pharman Limited. The views represented in the Journal are those of authors and not necessarily those of the Editor or Pharmacy Management. Pharman Ltd is not responsible for the content or accuracy of commercially generated material (e.g. advertisements, sponsored articles) but has the expectation that the originators of such material will ensure that it meets the requirements of the ABPI ‘Code of Practice for the Pharmaceutical Industry’ or other relevant guidance. Prescribing Information may be amended subsequent to publication of the journal so it is important to always consult the latest available version. Although great care has been taken to ensure the accuracy and completeness of the information contained in this publication, Pharman Limited nor any of its authors, contributors, employees or advisors is able to accept any legal liability for any consequential loss or damage, however caused, arising as a result of any actions taken on the basis of the information contained in this publication. Pharman Ltd is not responsible for the content of material that is available through hyperlinks. Efforts have been made to ensure that there is no infringement of copyright but please provide notification if any infringement is suspected. Pharman Limited welcomes requests for reproduction of the publication, in particular for educational purposes. Please contact the publishing office for information. Copyright © Pharman Limited The above composite logo is a registered Trade Mark owned by the publishers Pharman Limited. F A C U L T Y R O Y A L P H A R M A C E U T I C A L S O C I E T Y

RkJQdWJsaXNoZXIy MTk4OTA2